New China Life Insurance Reshapes Board Leadership and Committees for Ninth Session

New China Life Insurance Co., Ltd. Class H ( (HK:1336) ) just unveiled an announcement.

New China Life Insurance Company Ltd. has formed the ninth session of its board of directors, comprising 10 members including executive, non-executive and independent non-executive directors, and has elected executive director Yang Yucheng as chairman with immediate effect from the board’s first meeting on 24 December 2025. The company has also reconfigured its key board committees—covering strategy and ESG, investment and asset-liability management, audit and related-party transactions, nomination and remuneration, and risk management and consumer rights protection—assigning chairmanships and memberships to directors based on their roles and expertise, while noting that appointments involving incoming independent non-executive director Sau Fun Cheung will only take effect once her regulatory approval is obtained, with existing independent director Ma Yiu Tim continuing to serve in the interim, ensuring continuity of governance and oversight.

The most recent analyst rating on (HK:1336) stock is a Buy with a HK$60.00 price target. To see the full list of analyst forecasts on New China Life Insurance Co., Ltd. Class H stock, see the HK:1336 Stock Forecast page.

More about New China Life Insurance Co., Ltd. Class H

New China Life Insurance Company Ltd. is a major life insurer incorporated in the People’s Republic of China and listed in Hong Kong. The company focuses on providing life insurance and related protection products, operating under a board and committee structure that aligns with Chinese regulatory requirements and Hong Kong listing rules.

Average Trading Volume: 13,121,771

Technical Sentiment Signal: Buy

Current Market Cap: HK$221.8B

For an in-depth examination of 1336 stock, go to TipRanks’ Overview page.